ASX Share rice
Sun 16 May 2021 - 07:03:am (Sydney)

PAL Share Price

PALLA PHARMA LIMITEDPALPharmaceuticals, Biotechnology & Life Sciences

PAL Company Information

Name:

Palla Pharma Limited

Sector:

Consumer Defensive

Industry:

Farm Products

Address:

Tower 4 Melbourne VIC Australia 3008

Phone:

61 3 9301 0800

Interim CEO & CFO:

Mr. Brendan Middleton

Advisor:

Mr. Jarrod David Ritchie B.Sc., BSc (Hons)

Company Sec.:

Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, GAICD, GradDip CSP, FGIA

Company Overview:

Palla Pharma Limited, a vertically integrated pharmaceutical company, produces and distributes narcotic raw materials, active pharmaceutical ingredients, and finished dosage formulations for pharmaceutical markets in Australia and Norway. It also produces and distributes poppy seeds to culinary markets. The company was formerly known as TPI Enterprises Limited and changed its name to Palla Pharma Limited in June 2019. Palla Pharma Limited was incorporated in 2004 and is headquartered in Melbourne, Australia.

PAL Share Price Information

Shares Issued:

161.91M

Market Capitalisation:

$68M

Revenue (TTM):

$22.01M

Revenue Per Share (TTM):

$0.18

Earnings per Share:

$-0.087

Profit Margin:

-1.5791

Operating Margin (TTM):

$-0.87

Return On Assets (TTM):

$-0.15

Return On Equity (TTM):

$-0.65

Quarterly Revenue Growth (YOY):

-0.644

Gross Profit(TTM):

$-1,149,682

Diluted Earnings Per Share (TTM):

$-0.276

PAL CashFlow Statement

CashFlow Date:

2020-12-31

Investments:

$104.07K

Change To Liabilities:

$-893,237

Total Cashflow From Investing Activities:

$765.81K

Net Borrowings:

$12.54M

Net Income:

$-34,756,056

Total Cash From Operating Activities:

$-14,778,804

Depreciation:

$2.66M

Other Cashflow From Investing Activities:

$2.89M

Change To Inventory:

$-4,746,055

Change To Account Receivables:

$10.41M

Sale Purchase Of Stock:

$-3,104

Capital Expenditures:

$789.47K

PAL Income Statement

Income Date:

2020-12-31

Income Before Tax:

$-34,756,060

Net Income:

$-34,756,060

Gross Profit:

$-1,054,300

Operating Income:

$-32,720,010

Other Operating Expenses:

$1.89M

Interest Expense:

$2.06M

Total Revenue:

$22.11M

Cost Of Revenue:

$23.16M

PAL Balance Sheet

Balance Sheet Date:

2020-12-31

Intangible Assets:

$4.31M

Total Liabilities:

$31.30M

Total Stockholder Equity:

$36.12M

Other Current Liabilities:

$1.44M

Total Assets:

$67.42M

Common Stock:

$210.99M

Other Current Assets:

$816.70K

Retained Earnings:

$-177,938,467

Other Liabilities:

$1.75M

Other Assets:

$3.68M

Cash:

$609.67K

Total Current Liabilities:

$16.05M

Short-Term Debt:

$5M

Property - Plant & Equipment:

$24.27M

Net Tangible Assets:

$33.24M

Total Current Assets:

$36.58M

Long-Term Debt:

$13M

Net Receivables:

$7.50M

Short-Term Investments:

$30.83M

Inventory:

$26.89M

Accounts Payable:

$7.37M

Non Currrent Assets (Other):

$2.26M

Short-Term Investments:

$30.83

Non Current Liabilities Total:

$15.25M

PAL Share Price History

PAL News

02 Mar, 2021
Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic...
01 Dec, 2020
Palla Pharma Limited (ASX:PAL), is not the largest company out there, but it saw a decent share price growth in the...
27 Oct, 2020
We feel now is a pretty good time to analyse Palla Pharma Limited's (ASX:PAL) business as it appears the company may...
11 Sep, 2020
The CEO of Palla Pharma Limited (ASX:PAL) is Jarrod Ritchie, and this article examines the executive's compensation...
17 Jul, 2020
It is a pleasure to report that the Palla Pharma Limited (ASX:PAL) is up 37% in the last quarter. Meanwhile over the...